background current ebola virus erov detect method costly impact spider scenario differ immunebas assay report quantify protein particular sever monoclonal antibody mab describe bind caps glycoprotein gp howe current avail platform design product fulllength cumbersome use antibody fragment rather might metres costeffect alter develop diagnose possible even therapeutic alter methodsprincip find report express three recombin anti mab escherichia coli culture contain heavy light variable portion wellstudi c f kz consent name cfc ccff fake respect exhibit specify bind active lisa expert compare ie order magnitude easily economy product bacteria conclusionsignific use effect low cost relay capture diagnose applied 